The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Dazalex SC
Australian Public Assessment Report
Device/Product Name
Darzalex SC
Active ingredients
Daratumumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-04809-1-6
Submission Type
Extension of indications
Decision
Approved